Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology

Anne Stiggelbout*, Ingeborg Griffioen, Jasper Brands, Marijke Melles, Judith Rietjens, Marleen Kunneman, Marion Van Der Kolk, Casper Van Eijck, Dirk Snelders

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Treatment decision-making can be complex, notably when there are multiple treatments available, with different (probabilities of) benefits and harms, for example, survival and side effects.1 It is precisely in these complex situations that the preferences of the patient are of utmost importance, as the trade-offs of benefits and harms are subjective and concern patients' lives.2 In such trade-offs, shared decision making (SDM) has gained momentum as a strategy to include both the best available evidence and the patient's preferences.3

Original languageEnglish
Article numberbmjebm-2022-112168
Pages (from-to)291-294
Number of pages4
JournalBMJ Evidence-Based Medicine
Volume28
Issue number5
Early online date26 May 2023
DOIs
Publication statusPublished - 1 Oct 2023

Bibliographical note

Funding Information:
This study was funded by KWF Kankerbestrijding (UL-12072).

Publisher Copyright:
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Fingerprint

Dive into the research topics of 'Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology'. Together they form a unique fingerprint.

Cite this